Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 6
2007 5
2008 2
2009 1
2010 3
2011 5
2012 9
2013 6
2014 5
2015 4
2016 5
2017 2
2018 3
2019 5
2020 4
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.
Homerin G, Jawhara S, Dezitter X, Baudelet D, Dufrénoy P, Rigo B, Millet R, Furman C, Ragé G, Lipka E, Farce A, Renault N, Sendid B, Charlet R, Leroy J, Phanithavong M, Richeval C, Wiart JF, Allorge D, Adriouch S, Vouret-Craviari V, Ghinet A. Homerin G, et al. Among authors: farce a. J Med Chem. 2020 Mar 12;63(5):2074-2094. doi: 10.1021/acs.jmedchem.9b00584. Epub 2019 Sep 27. J Med Chem. 2020. PMID: 31525963
A computational view of COX-2 inhibition.
Chavatte P, Farce A. Chavatte P, et al. Among authors: farce a. Anticancer Agents Med Chem. 2006 May;6(3):239-49. doi: 10.2174/187152006776930909. Anticancer Agents Med Chem. 2006. PMID: 16712452 Review.
Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands.
Sansook S, Tuo W, Bollier M, Barczyk A, Dezitter X, Klupsch F, Leleu-Chavain N, Farce A, Tizzard GJ, Coles SJ, Spencer J, Millet R. Sansook S, et al. Among authors: farce a. Future Med Chem. 2018 Mar 1;10(6):631-638. doi: 10.4155/fmc-2017-0200. Epub 2018 Feb 8. Future Med Chem. 2018. PMID: 29419319 Free article.
65 results